Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 9,880.00
+490.00 (5.22%)
At close: Aug 20, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 151.82 billion as of August 20, 2026. Its market cap has decreased by -8.42% in one year.
Market Cap
151.82B
Enterprise Value
126.28B
Revenue
2.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,880.00
ChartMarket Cap Chart
Since December 5, 2023, Y-Biologics's market cap has decreased from 177.50B to 151.82B, a decrease of -14.46%. That is a compound annual growth rate of -5.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 151.82B | -56.32% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 221.23B |
| Kanaph Therapeutics | 194.82B |
| Bio Solution | 187.08B |
| NIBEC | 180.86B |
| Prestige Biologics | 144.31B |
| Ensol Biosciences | 141.69B |
| ISU Abxis | 135.78B |
| TiumBio | 133.67B |